Pura Vida Investments, LLC's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Jun 28, 2022
- Accession no.
- 0001209191-22-039692
- Filed
- Jun 28, 2022, 7:48 PM ET
- Trade date
- Jun 24, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $102.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pura Vida Investments, LLCCIK 0001590144 | 10% Owner |
| Kamen EfremCIK 0001789193 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 | Common Stock | SSaleDisposed | −10,964 | $1.05 | −$11,527.55 | 7,462,643 | Indirect | |
| Jun 24, 2022 | Common Stock | SSaleDisposed | −35,441 | $1.03 | −$36,394.36 | 7,427,202 | Indirect | |
| Jun 24, 2022 | Common Stock | SSaleDisposed | −12,517 | $1.05 | −$13,160.37 | 8,520,146 | Indirect | |
| Jun 24, 2022 | Common Stock | SSaleDisposed | −40,464 | $1.03 | −$41,552.48 | 8,479,682 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.